Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

doi:10.3748/wjg.v17.i6.735

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6276)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

571

HTML

5123

Figures (1-4)

370

Tables (1-4)

212

Sum=6276

Feb 14, 2011 (publication date) through Aug 25, 2024

Times Cited of This Article

Times Cited (63)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Feb 14, 2011; 17(6): 735-742
Published online Feb 14, 2011. doi: 10.3748/wjg.v17.i6.735

Table 3 Clinical and laboratory data of non-alcoholic fatty liver disease compared with obese children without liver disorder

	Group 0 (n = 274)	NAFLD
		Group 1 (n = 436)	Group 2 (n = 151)
Age (yr)	10.36 ± 2.15	10.59 ± 1.85	10.40 ± 2.28
BMI (kg/m²)	26.58 ± 3.19	28.85 ± 3.69^a	28.78 ± 3.96^a
BMI Z-score	3.17 ± 1.26	3.33 ± 1.37	3.93 ± 1.60^a^c
Waist circumference (cm)	85.63 ± 10.17	91.58 ± 11.24^a	92.2 ± 9.31^a
Father BMI (kg/m²)	25.12 ± 3.68	25.68 ± 5.78	25.55 ± 3.75
Mother BMI (kg/m²)	22.83 ± 3.14	23.46 ± 3.61^a	23.64 ± 3.38^a
Systolic blood pressure (mmHg)	113.62 ± 11.89	118.30 ± 13.37^a	118.03 ± 12.73^a
Diastolic blood pressure (mmHg)	67.80 ± 9.02	69.00 ± 9.38	69.43 ± 8.67^a
ALT (U/L)	24 (8-74)	29 (4-75)^a	51.5 (76-561)^a^c
Uric acid (μmol/L)	352.9 (186.5-603.20)	365.9 (168.10-708.50)^a	412.5 (7.38-771.30)^a^c
Triglycerides (mmol/L)	1.4 (0.19-6.76)	1.42 (0.26-5.90)	1.77 (0.28-8.64)^a^c
Cholesterol (mmol/L)	4.37 ± 0.99	4.34 ± 0.87	4.71 ± 0.99^a^c
HDL	1.29 ± 0.39	1.23 ± 0.28	1.22 ± 0.28
LDL	2.52 ± 0.66	2.54 ± 0.68	2.68 ± 0.78
AI	2.07 ± 0.73	2.15 ± 0.70	2.31 ± 0.92^a
Fasting blood glucose (mmol/L)	4.82 ± 0.52	4.88 ± 0.69	4.95 ± 0.55^a
30-min OGTT glucose (mmol/L)	7.54 ± 1.17	7.73 ± 1.24	7.69 ± 1.21
120-min OGTT glucose (mmol/L)	5.66 ± 1.36	6.31 ± 1.42^a	6.22 ± 1.63^a
HbA1c (%)	5.70 ± 0.50	5.71 ± 0.53	5.65 ± 0.62
Fasting insulin (mIU/L)	12.7 (0.3-187.0)	17.0 (0.3-219.0)^a	18.2 (2.1-303.0)^a
30-min OGTT insulin (mIU/L)	85.3 (1.8-400.0)	112.0 (0.5-400.0)^a	106.2 (1.6-400.0)^a
120-min OGTT insulin (mIU/L)	36.3 (3.2-400.0)	63.6 (1.7-386.0)^a	69.8 (7.0-400.0)^a
HOMA-IR	2.61 (0.07-41.56)	3.71 (0.08-51.59)^a	3.95 (0.48-78.11)^a
WBISI	4.0 (0.6-16.4)	2.8 (0.9-24.2)^a	2.6 (0.4-16.7)^a

^aP < 0.05 vs group 0;

^cP < 0.05, group 1 vs group 2. Data are expressed as mean ± SD or median (range). NAFLD: Non-alcoholic fatty liver disease; BMI: Body mass index; ALT: Alanine aminotransferase; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; AI: Atherogenic index; OGTT: Oral glucose tolerance test; HOMA-IR: Homeostasis model assessment of insulin resistance; WBISI: Whole-body insulin sensitivity index.

Citation: Fu JF, Shi HB, Liu LR, Jiang P, Liang L, Wang CL, Liu XY. Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children? World J Gastroenterol 2011; 17(6): 735-742
URL: https://www.wjgnet.com/1007-9327/full/v17/i6/735.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i6.735